A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to AbbVie
Related studies linked through entity extraction aliases.
Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Viekira/Exviera for Korean Hepatitis C Patients According to the Standard for Re-examination of New Drugs
- Status
- COMPLETED
- Phase
- N/A
Chamas for Change Validation
- Status
- UNKNOWN
- Phase
- NA
A Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE2
Impact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
Role of the Host Immunity in the Non-response to Direct Anti-viral Agent (DAA) Therapy
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis
- Status
- TERMINATED
- Phase
- PHASE1
A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)
- Status
- TERMINATED
- Phase
- PHASE1
SC-004 Alone or With ABBV-181 in Subjects With Epithelial Ovarian, Fallopian Tube, Primary Peritoneal and Endometrial Cancers
- Status
- TERMINATED
- Phase
- PHASE1
Expanded Access to Glecaprevir/ Pibrentasvir
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Expanded Access to ABT-414
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Expanded Access to Veliparib
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Expanded Access to Venetoclax
- Status
- AVAILABLE
- Phase
- N/A
A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment
- Status
- COMPLETED
- Phase
- PHASE3
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)
- Status
- COMPLETED
- Phase
- PHASE3